Cargando…

Expression and Clinical Significance of TIGIT in Primary Breast Cancer

PURPOSE: The roles of T cell immunoreceptor with Ig and ITIM domains (TIGIT) in the diagnosis of primary breast cancer (PBC) are still unclear. This study was designed to investigate the expression of TIGIT in PBC patients, with an aim to analyze its diagnostic value in PBC. PATIENTS AND METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Limin, Sha, Min, Guo, Ting, Lu, Huimin, Qian, Jingyu, Shao, Qixiang, Ye, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275376/
https://www.ncbi.nlm.nih.gov/pubmed/37333881
http://dx.doi.org/10.2147/IJGM.S407725
_version_ 1785059860492058624
author Tang, Limin
Sha, Min
Guo, Ting
Lu, Huimin
Qian, Jingyu
Shao, Qixiang
Ye, Jun
author_facet Tang, Limin
Sha, Min
Guo, Ting
Lu, Huimin
Qian, Jingyu
Shao, Qixiang
Ye, Jun
author_sort Tang, Limin
collection PubMed
description PURPOSE: The roles of T cell immunoreceptor with Ig and ITIM domains (TIGIT) in the diagnosis of primary breast cancer (PBC) are still unclear. This study was designed to investigate the expression of TIGIT in PBC patients, with an aim to analyze its diagnostic value in PBC. PATIENTS AND METHODS: We first explore the expression of TIGIT in cancer patients based on TCGA database, and then we analyzed its correlation with clinicopathological features. Afterwards, we compared the protein and mRNA expressions of TIGIT in two BC cell lines (MCF-7 and MDA-MB-231) and normal breast epithelial cell line (MCF-10A). Subsequently, 56 PBC female patients admitted to the Taizhou People’s Hospital from October 2018 to June 2021 were included in this study. Flow cytometry was used to detect TIGIT level on peripheral blood CD3(+) T cells of PBC patients and healthy controls. TIGIT expression in PBC tissues was detected by immunohistochemistry (IHC) and immunofluorescence staining. RESULTS: TCGA database showed that compared with adjacent tissues, TIGIT was significantly upregulated in tumor tissues. High TIGIT expression was positively correlated with tumor stage and negatively correlated with recurrence free survival (RFS) and overall survival (OS). TIGIT level in BC cell lines, peripheral blood and tumor tissues of PBC patients was significantly higher than that of control (P < 0.05). TIGIT level was correlated with age (P < 0.05), rather than tumor size, pathological type, lymph node metastasis, ER, PR, HER-2, and P53. ROC curve showed that the optimal critical value of peripheral blood TIGIT for BC screening was 23.38%. Postoperative TIGIT level in peripheral blood was significantly decreased compared to the preoperative TIGIT level (P < 0.05). CONCLUSION: TIGIT was upregulated in PBC and was correlated with age. It may be a potential target for the diagnosis and immunotherapy of PBC.
format Online
Article
Text
id pubmed-10275376
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-102753762023-06-17 Expression and Clinical Significance of TIGIT in Primary Breast Cancer Tang, Limin Sha, Min Guo, Ting Lu, Huimin Qian, Jingyu Shao, Qixiang Ye, Jun Int J Gen Med Original Research PURPOSE: The roles of T cell immunoreceptor with Ig and ITIM domains (TIGIT) in the diagnosis of primary breast cancer (PBC) are still unclear. This study was designed to investigate the expression of TIGIT in PBC patients, with an aim to analyze its diagnostic value in PBC. PATIENTS AND METHODS: We first explore the expression of TIGIT in cancer patients based on TCGA database, and then we analyzed its correlation with clinicopathological features. Afterwards, we compared the protein and mRNA expressions of TIGIT in two BC cell lines (MCF-7 and MDA-MB-231) and normal breast epithelial cell line (MCF-10A). Subsequently, 56 PBC female patients admitted to the Taizhou People’s Hospital from October 2018 to June 2021 were included in this study. Flow cytometry was used to detect TIGIT level on peripheral blood CD3(+) T cells of PBC patients and healthy controls. TIGIT expression in PBC tissues was detected by immunohistochemistry (IHC) and immunofluorescence staining. RESULTS: TCGA database showed that compared with adjacent tissues, TIGIT was significantly upregulated in tumor tissues. High TIGIT expression was positively correlated with tumor stage and negatively correlated with recurrence free survival (RFS) and overall survival (OS). TIGIT level in BC cell lines, peripheral blood and tumor tissues of PBC patients was significantly higher than that of control (P < 0.05). TIGIT level was correlated with age (P < 0.05), rather than tumor size, pathological type, lymph node metastasis, ER, PR, HER-2, and P53. ROC curve showed that the optimal critical value of peripheral blood TIGIT for BC screening was 23.38%. Postoperative TIGIT level in peripheral blood was significantly decreased compared to the preoperative TIGIT level (P < 0.05). CONCLUSION: TIGIT was upregulated in PBC and was correlated with age. It may be a potential target for the diagnosis and immunotherapy of PBC. Dove 2023-06-12 /pmc/articles/PMC10275376/ /pubmed/37333881 http://dx.doi.org/10.2147/IJGM.S407725 Text en © 2023 Tang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Tang, Limin
Sha, Min
Guo, Ting
Lu, Huimin
Qian, Jingyu
Shao, Qixiang
Ye, Jun
Expression and Clinical Significance of TIGIT in Primary Breast Cancer
title Expression and Clinical Significance of TIGIT in Primary Breast Cancer
title_full Expression and Clinical Significance of TIGIT in Primary Breast Cancer
title_fullStr Expression and Clinical Significance of TIGIT in Primary Breast Cancer
title_full_unstemmed Expression and Clinical Significance of TIGIT in Primary Breast Cancer
title_short Expression and Clinical Significance of TIGIT in Primary Breast Cancer
title_sort expression and clinical significance of tigit in primary breast cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275376/
https://www.ncbi.nlm.nih.gov/pubmed/37333881
http://dx.doi.org/10.2147/IJGM.S407725
work_keys_str_mv AT tanglimin expressionandclinicalsignificanceoftigitinprimarybreastcancer
AT shamin expressionandclinicalsignificanceoftigitinprimarybreastcancer
AT guoting expressionandclinicalsignificanceoftigitinprimarybreastcancer
AT luhuimin expressionandclinicalsignificanceoftigitinprimarybreastcancer
AT qianjingyu expressionandclinicalsignificanceoftigitinprimarybreastcancer
AT shaoqixiang expressionandclinicalsignificanceoftigitinprimarybreastcancer
AT yejun expressionandclinicalsignificanceoftigitinprimarybreastcancer